Opentrons

Opentrons

A company building robots to automate experiments of life scientists

In March 2018, Opentrons announced the launch of its newest lab robot, OT-2 and new no-code Protocol Designer. The OT-2 release is supported by the close of a $10M seed funding round, led by Khosla Ventures with participation from Lerer Hippeau Ventures, Y Combinator Continuity Fund, and Jeff Kindler, former CEO of Pfizer. This launch and financial backing furthers Opentrons' mission to bring affordable automation to any biologist.

Founded out of Brooklyn in 2013, Opentrons's stated goal is to save researchers from having to carry out repetitive tasks.

Timeline

March 2018
Opentrons raises a $10,000,000 seed round from Jeffrey B. Kindler, Khosla Ventures, Lerer Hippeau Ventures and YC Continuity.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Opentrons Seed round, March 2016
April 1, 2016
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Alfie Umbhau

Employee

Andy Sigler

Employee

Artyom Astafurov

Employee

Benjamin Morris

Employee

Chiu Chau

Co-founder, CTO

Chon Tang

Investor

Gil Seton

Investor

Jenny Vu

Employee

Jon Martinez

Employee

Jonathan Badal

CEO

Katie Adee

Employee

Kristin Ellis

Employee

Lev Kravinsky

Employee

Lucy Volland

Employee

Matthew Monsees

Employee

Michelle Steigerwalt

Employee

Mike Cousins

Employee

Mike Fitzgerald

Employee

Mitch Dunn

Employee

Pantea Razzaghi

Employee

Will Canine

Co-founder, CPO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.